Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 33 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 8058280

    Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  2. US 8057990

    Screening method

    Takeda Pharmaceutical Company Limited · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  3. US 8048909

    Proton pump inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

  4. US 8044049

    Fused heterocyclic derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  5. US 8039500

    Fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  6. US 8034812

    Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  7. US 8030333

    Benzimidazole compound crystal

    Takeda Pharmaceutical Company Limited · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  8. US 8030337

    Tricyclic compound and pharmaceutical use thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  9. US 8030317

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  10. US 8026234

    Polo-like kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 27, 2011 · Expires Sep 22, 2031

    granted

  11. US 8022057

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  12. US 8013008

    Cyclic amine compound

    Takeda Pharmaceutical Company Limited · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  13. US 8008525

    Receptor function regulating agent

    Takeda Pharmaceutical Company Limited · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  14. US 8003785

    Halo-substituted pyrimidodiazepines

    Takeda Pharmaceutical Company Limited · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  15. US 7998684

    Screening method for an agent for treatment of neurodegenerative disease

    Takeda Pharmaceutical Company Limited · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  16. US 7998968

    Substituted pyrimidines and [1,2, 4] triazoles and the use thereof for treating prophylaxis, cardiovascular diseases, metabolic diseases and/or central nervous system diseases

    Takeda Pharmaceutical Company Limited · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  17. US 7994332

    Process for producing crystal

    Takeda Pharmaceutical Company Limited · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  18. US 7994205

    Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  19. US 7994183

    Solid preparation comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile

    Takeda Pharmaceutical Company Limited · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  20. US 7989445

    Thienopyrimidone compound

    Takeda Pharmaceutical Company Limited · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  21. US 7985862

    Iminopyridine derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 26, 2011 · Expires Jul 21, 2031

    granted

  22. US 7985863

    Iminopyridine derivatives and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 26, 2011 · Expires Jul 21, 2031

    granted

  23. US 7982044

    Iminopyridine derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  24. US 7981598

    Preventive/remedy for respiratory diseases

    Takeda Pharmaceutical Company Limited · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.